SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (OTCQB:MNTR) announces that the leaders in Mentor’s new Cannabis Index for Value Investors were Mentor Capital at (252%), Terra Tech (OTCQX:TRTC) at (86%) and GW Pharmaceuticals Plc. (NASDAQ: GWPH) at (33%) when compared to the NASDAQ average set at (100%). Sales plus book value were compared to market capitalization for leading marijuana stocks to establish this new marijuana stock index.
“The Mentor Capital Cannabis Index for Value Investors is intended to provide an alternative business value focused metric for investors to examine, as opposed to the plethora of share price tracking compilations common around cannabis stocks. Momentum, technical analysis, day trading and chart watching are susceptible to stock manipulation schemes while value investing is less so,” counsels Mentor CEO, Chet Billingsley. “Mentor Capital is pleased that our value focused investment approach has paid off in increasing Mentor book value and revenue per share ratios which now more than double that of the Nasdaq Composite Index, which itself outstrips typical cannabis ratios.
“For interested investors, we will publish our cannabis index and comparative value oriented ratios at our company website regularly,” affirms Billingsley. “As required, Mentor does not provide any investment advisory, purchase or price recommendations from the historical financial information we portray.” Other marijuana stocks of interest and their respective ratios to NASDAQ in the growing index include: Cannabis Science Inc. (OTCMkts:CBIS) at (-20); Hemp, Inc. (OTCMkts:HEMP) at (10%); MassRoots, Inc. (OTCQB:MSRT) at (3%); and Medbox, Inc. (OTCQB:MDBX) at (-684%).
About Mentor Capital: The Company seeks to come alongside and assist medical marijuana and cannabis companies and their founders in meeting their financial objectives, to add protection for investors and to help incubate private cannabis companies. Additional important information for investors is presented at: www.MentorCapital.com .
This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.
Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales, problems securing the necessary financing to continue operations, problems involving continued illegality of cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, in recruiting knowledgeable personnel and in protecting intellectual property. Further information concerning these and other risks is included in the Company’s 10-K and 10-Q filings including the Company’s most recent Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 which, along with other very important information about the Company, can be found filed with the SEC and here:
The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events or circumstances occurring after the date of this press release.